BiotechTube
Forest Devices

Forest Devices

Pittsburgh, United States· Est.
forestdevices.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Forest Devices is a private, clinical-stage medical device company pioneering point-of-care technology for stroke assessment. Its flagship product, AlphaStroke, is an AI-powered, electrode-based device designed to detect large vessel occlusion (LVO) strokes in minutes, addressing a critical bottleneck in the stroke care pathway. The company is positioned to capture value in the growing neurodiagnostic market by reducing time-to-treatment, which is directly linked to improved patient recovery and reduced healthcare costs. Backed by venture capital and strategic grants, Forest Devices is advancing through clinical validation and regulatory milestones toward commercialization.

NeurologyStroke

Technology Platform

AI-powered electroencephalogram (EEG) analysis platform for rapid, point-of-care detection of neurological emergencies, starting with large vessel occlusion (LVO) stroke.

Opportunities

The massive unmet need for rapid stroke triage creates a large addressable market in emergency medical services and hospital emergency departments globally.
Successful deployment of AlphaStroke could establish a new standard of care, reducing time-to-treatment and significantly improving patient outcomes and cost savings for healthcare systems.
The core EEG/AI platform also offers potential for expansion into other acute neurological conditions like traumatic brain injury or seizure monitoring.

Risk Factors

The company faces significant clinical risk that its device may not achieve the necessary sensitivity and specificity in larger trials for regulatory approval.
Post-approval, market adoption by EMS and hospitals is non-trivial and requires changing established protocols, and securing adequate insurance reimbursement is a critical, lengthy challenge.
Competition from other emerging technologies in the neurodiagnostic space also presents a material risk.

Competitive Landscape

The competitive landscape for pre-hospital stroke detection includes other startups developing technologies like volumetric impedance phase shift spectroscopy (e.g., Cerebrotech) and alternative EEG-based algorithms. Established medtech companies in the stroke thrombectomy space (e.g., Medtronic, Stryker) could also develop or acquire competing triage tools. Forest Devices' focus on a simple, EMS-friendly form factor and AI-driven automation is a key differentiator in this emerging field.

More companies in Diagnostics & Precision Medicine →More companies in United States →